Company: BSX
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000885725-25-000011
Chunk: 167

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 167
---
 lease payments for lease terms that have not yet commenced.

NOTE G – SUPPLEMENTAL BALANCE SHEET INFORMATION Components of selected captions in our accompanying consolidated balance sheets are as follows:Trade accounts receivable, net As of December 31,(in millions)20242023Trade accounts receivable$2,667 $2,338 Allowance for credit losses(109)(110) $2,558 $2,228 The following is a roll forward of our Allowance for credit losses:Year Ended December 31,(in millions)202420232022Beginning balance$110 $109 $108 Credit loss expense41 50 35 Write-offs(43)(48)(35)Ending balance$109 $110 $109 

99

Inventories As of December 31,(in millions)20242023Finished goods$1,798 $1,537 Work-in-process193 174 Raw materials819 773  $2,810 $2,484 Approximately 22 percent of our finished goods inventory as of December 31, 2024 and 2023 was at customer locations pursuant to consignment arrangements or held by sales representatives.Other current assets As of December 31,(in millions)20242023Restricted cash and restricted cash equivalents$111 $130 Derivative assets305 159 Other414 332  $831 $621 Property, plant and equipment, net As of December 31,(in millions)20242023Land$144 $140 Buildings and improvements2,019 1,843 Equipment, furniture and fixtures3,630 3,503 Capital in progress1,035 857  6,827 6,343 Less: accumulated depreciation3,533 3,484  $3,294 $2,859 Depreciation expense was $412 million in 2024, $367 million in 2023 and $333 million in 2022.Other long-term assets As of December 31,(in millions)20242023Restricted cash equivalents$80 $60 Operating lease right-of-use assets449 439 Derivative assets79 107 Investments555 413 Indemnification asset188 176 Other402 336  $1,754 $1,531 

100

Accrued expenses As of December 31,(in millions)20242023Legal